about
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsFluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cellsEffects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activityThe alpha helix of ubiquitin interacts with yeast cyclin-dependent kinase subunit CKS1.Interactions of amphipathic carrier peptides with membrane components in relation with their ability to deliver therapeutics.Interactions of primary amphipathic cell penetrating peptides with model membranes: consequences on the mechanisms of intracellular delivery of therapeutics.Interactions of amphipathic CPPs with model membranes.Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis.Spotlight on fluorescent biosensors-tools for diagnostics and drug discovery.Translocating peptides and proteins and their use for gene delivery.Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cellsFluorescent biosensors for high throughput screening of protein kinase inhibitors.Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells.Tampering with cell division by using small-molecule inhibitors of CDK-CKS protein interactions.A non-covalent peptide-based carrier for in vivo delivery of DNA mimics.Conformational Equilibrium of CDK/Cyclin Complexes by Molecular Dynamics with Excited Normal Modes.Cell-penetrating peptides: tools for intracellular delivery of therapeutics.Carbon nanotube biosensors.A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction.A non-covalent peptide-based strategy for siRNA delivery.Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.Cell-penetrating peptides: from molecular mechanisms to therapeutics.Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growthPeptide-based nanoparticle for ex vivo and in vivo drug delivery.Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes.PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.Cell-cycle markers and biosensors.Fluorescent sensors of protein kinases: from basics to biomedical applications.Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.Light controllable siRNAs regulate gene suppression and phenotypes in cells.A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.Fluorescent peptide biosensor for monitoring CDK4/cyclin D kinase activity in melanoma cell extracts, mouse xenografts and skin biopsies.Characterization of centrosomal localization and dynamics of Cdc25C phosphatase in mitosis.The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes.An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins.A peptide carrier for the delivery of biologically active proteins into mammalian cells.Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.Differential phosphorylation of Cdc25C phosphatase in mitosis.
P50
Q26827580-C552ED49-D169-490D-9903-8E27EA9B47FDQ27315827-44D97FE6-C639-434F-AA0E-B3122575B5FDQ27617593-FA9B2EB1-86FC-47CD-8931-64F06F0336B5Q27939208-41BD0EA3-C3ED-40FA-BD70-8932F20B2683Q30159547-45CAA44F-FB31-4686-9B0A-C0AF617525E2Q30160047-0F4DEA31-E7A0-437A-8272-716F07609E6BQ30160070-0D3BBA1F-2719-4B22-9727-5436662AB0CCQ30892744-A5253BE3-729B-4858-B29B-AEF466F51DEDQ33636538-089BDBAC-3FAD-4E7E-9BEB-3846F06B26E7Q34056573-61B595CD-666B-492D-AF28-7E4708CAF3E8Q35031898-3D87A21E-9A0F-4CA0-A4F1-A536675D1756Q35072414-14FDBFB5-70C6-424C-8D4C-4E3969033FD4Q35161237-DD8D83BB-2D96-4A5C-92E8-123261D2A7CBQ35548864-F706C8DD-F411-489A-8265-662BD087E1FCQ35804697-42F9F517-DFD8-4E55-888C-F4A77B54967BQ36076199-C0208D12-4C74-44E6-881F-8119EF6AE833Q36169402-BE5BA5CD-0443-4AFA-A278-DFC33A95B74FQ36209397-30AD46F1-1DAE-4760-A544-ADB34A763EECQ36424362-0EE43AC3-74EE-4F51-9D9C-30D08D2E6634Q36711326-6497E063-CFBC-4948-8125-02E537198D4FQ37013962-9883B610-525D-4460-AB31-2F0ECC874AA5Q37110276-56490B5E-403C-4E4C-B3FF-539A41821822Q37230918-0A734836-0EC7-492F-A368-869C85CF032EQ37298570-F31665A9-9DD9-43B8-8556-F7F8B3941C1EQ37347454-CFB54545-7AF0-494F-882E-BC60D691AF0CQ37634414-EE1BA0DE-E38F-4683-992A-4F961B3CDB01Q37699647-7547D334-0CDE-4B48-A1E4-16A70823E85CQ37732060-C4DACAC9-34D6-4FD2-A778-B38CB0D18D17Q38067854-B567570C-9369-40B0-ADD4-619F9A32F738Q38078701-E3C28B45-A73D-42D0-AD50-6577E5F68DC3Q38260166-991F804D-6817-4F70-BBFF-659DCA92B83DQ38315532-C5E93747-0251-4C42-9BC6-31F129212F07Q38344289-FB9962F6-ED08-47F6-9155-BA632C9FF3A3Q38769671-75080FEA-D237-41F3-903C-06680392663AQ39964624-F153F399-A92A-4119-BFD1-6690A7F7FAE3Q40164867-11650306-E67C-4EDF-BC99-A3AE79859F2AQ41743019-E31CAFC4-EBF9-4D8E-8426-DC1775D2D64DQ42823248-400C98C1-B9AC-4B05-BECA-AE6FD7CE09AAQ43963596-066BE7E2-52D4-47F9-918F-040B8737689BQ44138375-086A4423-50CE-42B6-BE56-3D758E8B059A
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
May Morris
@ast
May Morris
@en
May Morris
@es
May Morris
@nl
May Morris
@sl
type
label
May Morris
@ast
May Morris
@en
May Morris
@es
May Morris
@nl
May Morris
@sl
prefLabel
May Morris
@ast
May Morris
@en
May Morris
@es
May Morris
@nl
May Morris
@sl
P214
P1053
J-5940-2016
P-2961-2016
P106
P21
P214
P2798
P31
P3829
P496
0000-0001-8106-9728
P569
2000-01-01T00:00:00Z
P734
P735
P7859
viaf-314845638